Article
Inhibition of miR338 rescues cleidocranial dysplasia in Runx2 mutant mice partially via the Hif1a-Vegfa axis.
Experimental & molecular medicine - 1 Jan 2023
Jin Runze, Zhang Hanshu, Lin Chujiao, Guo Jinqiang, Zou Weiguo, Chen Zhi, Liu Huan
Abstract excerpt
Haploinsufficiency of Runt-related transcription factor-2 (RUNX2) is responsible for cleidocranial dysplasia (CCD), a rare hereditary disease with a range of defects, including delayed closure of the cranial sutures and short stature. Symptom-based treatments, such as a combined surgical-orthodontic approach, are commonly used to treat CCD patients. However, there have been few reports of treatments based on...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
